C1qTNF5/CTRP5 Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

C1qTNF5/CTRP5 Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 15 amino acids near the amino terminus of human CTRP5.

  Source: Synthetic

  (Accession #: AAQ88749)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: C1QTNF5
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-76631.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for C1qTNF5/CTRP5 Antibody Blocking Peptide

• C1q and tumor necrosis factor related protein 5
• C1qTNF5
• Complement C1q Tumor Necrosis Factor-Related Protein 5 Precursor Variant 3
• CTRP5
• CTRP5LORDDKFZp586B0621
• LORD 6
• Myonectin 3

Background

Defects in C1QTNF5 are a cause of late-onset retinal degeneration (LORD). LORD is an autosomal dominant disorder characterized by onset in the fifth to sixth decade with night blindness and punctate yellow-white deposits in the retinal fundus, progressing to severe central and peripheral degeneration, with choroidal neovascularization and chorioretinal atrophy.; Subcellular location: Secreted

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: C1QTNF5